Evidence Hub

Urothelial carcinoma in situ of the entire urinary tract with invasion into seminal vesicle: A case report

V. Hsu, Nicole Swarbrick, Hemant Kulkarni, A. Redfern, C. Hawks, Alarick Picardo, S. McCombie, D. Hayne

Urology Case Reports, 2025

1 citation

Abstract

Urothelial carcinoma in situ represents a high-grade, high-risk form of urothelial cancer which predominantly occurs within the bladder, rarely affecting other structures within the genitourinary system such as the seminal vesicle. Involvement could represent more advanced disease, necessitating more aggressive management. We present a case of CIS involving the entire urinary tract in a renal transplant patient who underwent a complete urinary tract extirpation (CUTE) for BCG-refractory CIS of the bladder. This case is unique, representing the first reported CUTE with malignant involvement of every site in the urinary tract.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free